4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-17-027487
Director sold 1,900 shares at an average $20.21 ($38,406)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Woiwode Thomas Director | 2017-11-24 | Sale | −1,700 | $20.21 | $34,358 | 8,218 | D |
| Woiwode Thomas Director | 2017-11-27 | Sale | −200 | $20.24 | $4,048 | 8,018 | D |
| Open-market sales · 1,900 sh · avg $20.21 · $38,406 | |||||||
Loading xslF345X03/doc4.xml…